Based on other studies, using claudin18.2-CAR T cells [74], NKG2D-CAR T cells [75], folate receptor 1 (FOLR1)-CAR T cells [76], and HER2-CAR T cells [77] can be considered as a novel therapeutic approach for gastric cancer therapy. Here, FOLR1 is linked to gastric cancer.